Fabino Life Sciences Limited reported earnings results for the full year ended March 31, 2024. For the full year, the company reported sales was INR 210.83 million compared to INR 33.6 million a year ago. Revenue was INR 210.93 million compared to INR 33.83 million a year ago.

Net income was INR 0.358 million compared to INR 0.108 million a year ago. Basic earnings per share from continuing operations was INR 0.17 compared to INR 0.05 a year ago. Diluted earnings per share from continuing operations was INR 0.17 compared to INR 0.05 a year ago.